Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Liver Cirrhosis Global Clinical Trials Review, H1

Liver Cirrhosis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Liver Cirrhosis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Liver Cirrhosis Global Clinical Trials Review, H1, 2015" provides an overview of Liver Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Liver Cirrhosis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Liver Cirrhosis 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Liver Cirrhosis Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Liver Cirrhosis 34

May 14, 2015: Galectin Therapeutics Reports no Drug-Drug Interaction Between GR-MD-02 and Midazolam 34

Apr 24, 2015: New Proof Of Efficacy Of Gft505 In Nash And Positive Expert Opinion 34

Mar 26, 2015: Genfit Announces Topline Results From The Golden-505 Trial In Nash 35

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

Merck & Co., Inc. 37

Clinical Trial Overview of Merck & Co., Inc. 37

Sanofi 38

Clinical Trial Overview of Sanofi 38

Novartis AG 39

Clinical Trial Overview of Novartis AG 39

F. Hoffmann-La Roche Ltd. 40

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40

Valeant Pharmaceuticals International, Inc. 41

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 41

GlaxoSmithKline plc 42

Clinical Trial Overview of GlaxoSmithKline plc 42

Conatus Pharmaceuticals Inc. 43

Clinical Trial Overview of Conatus Pharmaceuticals Inc. 43

C. H. Boehringer Sohn AG & Co. KG 44

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 44

Genextra S.p.a. 45

Clinical Trial Overview of Genextra S.p.a. 45

Astellas Pharma Inc. 46

Clinical Trial Overview of Astellas Pharma Inc. 46

Clinical Trial Overview of Top Institutes / Government 47

The National Institute of Diabetes and Digestive and Kidney Diseases 47

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 47

Sun Yat-sen University 48

Clinical Trial Overview of Sun Yat-sen University 48

Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 49

Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 49

Hospital Clinic de Barcelona 50

Clinical Trial Overview of Hospital Clinic de Barcelona 50

National Center for Research Resources 51

Clinical Trial Overview of National Center for Research Resources 51

Royal Prince Alfred Hospital 52

Clinical Trial Overview of Royal Prince Alfred Hospital 52

Shandong Provincial Hospital 53

Clinical Trial Overview of Shandong Provincial Hospital 53

Assistance Publique-Hopitaux de Paris 54

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 54

Baermed 55

Clinical Trial Overview of Baermed 55

Federal University of Rio de Janeiro 56

Clinical Trial Overview of Federal University of Rio de Janeiro 56

Five Key Clinical Profiles 57

Appendix 80

Abbreviations 80

Definitions 80

Research Methodology 81

Secondary Research 81

About GlobalData 82

Contact Us 82

Disclaimer 82

Source 82

List of Figures

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Liver Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liver Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liver Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Liver Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Liver Cirrhosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Liver Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Liver Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Liver Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liver Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Liver Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liver Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Liver Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liver Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liver Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Liver Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Liver Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Liver Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Liver Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 81

List of Tables

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Liver Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liver Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liver Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Liver Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Liver Cirrhosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Liver Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Liver Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Liver Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liver Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liver Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Liver Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liver Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Liver Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Liver Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liver Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liver Cirrhosis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Liver Cirrhosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Liver Cirrhosis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Liver Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Liver Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Liver Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Liver Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Liver Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 37

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 38

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 39

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 40

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 41

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 42

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Conatus Pharmaceuticals Inc., 2015* 43

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 44

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 45

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 46

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 47

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 48

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015* 49

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 50

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015* 51

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Prince Alfred Hospital, 2015* 52

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong Provincial Hospital, 2015* 53

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 54

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baermed, 2015* 55

Liver Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Rio de Janeiro, 2015* 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Merck & Co., Inc.

Sanofi

Novartis AG

F. Hoffmann-La Roche Ltd.

Valeant Pharmaceuticals International, Inc.

GlaxoSmithKline plc

Conatus Pharmaceuticals Inc.

C. H. Boehringer Sohn AG & Co. KG

Genextra S.p.a.

Astellas Pharma Inc.

Liver Cirrhosis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Liver Cirrhosis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com